Yep? Glad I own.... cannot wait for them to turn this into a treatment..... now we can start speculation on who the potential parters with established distribution channels are exactly........ Surgecentre? or are they thinking another drug treatment provider I wonder......
All the people claiming MSB failed to design the trial endpoints just had a reality check confirmed. Msb wanted pain reduction, FDA insisted on treating cells as a device and wanted other data... now fda realise they were wrong and are allowing msb to go for pain.....
massive market... no other treatment... and the surgeon in the interview said about 30% pain reduction for spinal surgery which is a last resort, and which requires more surgeries after about 4 years, then more, then more..... the exact words were that the msb treatment was " a no brainer" and his clinic had been bugging msb trying to get more cells to use after the trial finished.... because there is nothing else....
Chronic Lower Back Pain - the sleeping giant., page-142
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.010(0.69%) |
Mkt cap ! $1.678B | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.50 | $1.46 | $1.535M | 1.038M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 10234 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.47 | 17318 | 8 |
View Market Depth
| Last trade - 10.59am 14/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |